6826 — Shanghai Haohai Biological Technology Co Balance Sheet
0.000.00%
Last trade - 00:00- HK$5.70bn
- HK$3.65bn
- CNY2.70bn
- 75
- 69
- 47
- 72
Annual balance sheet for Shanghai Haohai Biological Technology Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | CAS | CAS | CAS | CAS | CAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 3,115 | 2,912 | 2,548 | 2,760 | 2,725 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 345 | 390 | 428 | 398 | 387 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 3,810 | 3,713 | 3,532 | 3,750 | 3,658 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1,037 | 1,241 | 1,401 | 1,548 | 1,761 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 6,299 | 6,950 | 6,892 | 7,105 | 7,121 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 434 | 487 | 511 | 716 | 866 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 808 | 1,237 | 1,378 | 1,455 | 1,546 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 5,491 | 5,713 | 5,515 | 5,650 | 5,575 |
| Total Liabilities & Shareholders' Equity | 6,299 | 6,950 | 6,892 | 7,105 | 7,121 |
| Total Common Shares Outstanding |